학술논문

Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial
Document Type
Article
Author
Welzel, TatjanaAtkinson, AndrewSchöbi, NinaAndre, Maya CBailey, Douggl G NBlanchard-Rohner, GeraldineBuettcher, MichaelGrazioli, SergeKoehler, HenrikPerez, Marie-HeleneTrück, JohannesVanoni, FedericaZimmermann, PetraSanchez, CarlosBielicki, Julia ASchlapbach, Luregn JBieri, AndreasGysi, SpyridoulaJanz, IndraDonner, BirgitHammer, JürgHeininger, UlrichKohns Vasconcelos, MalteMettauer, NicoleMeyer, AlexandraReppucci, DianaSchlaeppi, ChloéTrachsel, DanielVaezipour, Ninavon Kalckreuth, ClemensWoerner, AndreasZutter, AndreasKottanattu, LisaMazzara, CalogeroSeveri Conti, AlessiaAebi, ChristophAgyeman, Philipp K ADuppenthaler, AndreaGlöckler, MartinPallivathukal, SabineRiedel, ThomasCudré-Cung, Hong-PhucPavlovic, MladenBordessoule, AliceL'Huillier, Arnaud GMartin, Anne-LaurePolito, AngeloRohr, MarieRodriguez, Maria IsabelWagner, NoemieChanez, VivianneBressieux-Degueldre, SabrinaFerry, ThomasHofer, MichaelLongchamp, DavidNatterer, JuliaOppenheim, RebeccaDonas, AlexGermann, SaraHrup, KatjaKaiser, DanielaKuen, Hans PeterLütolf Erni, MichaelaSchwendener Scholl, KatharinaStritt, JanineWechselberger, KatharinaBeck, IngridBirkenmaier, AndréFlade, MartinRogdo, BjarteIglowstein, IvoLorenz, PhilipWachinger, TanjaZöhrer, KonstanzeBrotschi, BarbaraMeyer Sauteur, Patrick MPachlopnik Schmid, JanaPrader, SerainaSeiler, MichelleWeber, KathrinWütz, DanielaWhittaker, ElizabethFaust, Saul N
Source
The Lancet Child & Adolescent Health; April 2023, Vol. 7 Issue: 4 p238-248, 11p
Subject
Language
ISSN
23524642; 23524650
Abstract
The emergence of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) led to the widespread use of anti-inflammatory treatments in the absence of evidence from randomised controlled trials (RCTs). We aimed to assess the effectiveness of intravenous methylprednisolone compared with intravenous immunoglobulins.